ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,267Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 1006

$1.59M Total Retail Price of All Prescriptions

Rank: 13 out of 1006

659 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 659 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 659 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 11,119 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$104 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 509 398 1 1
LEVOTHYROXINE SODIUM 399 271 2 2
FUROSEMIDE 368 288 3 6
OMEPRAZOLE 366 254 4 9
ATORVASTATIN CALCIUM 346 274 5 5
LISINOPRIL 324 253 6 3
METOPROLOL TARTRATE 267 236 7 7
WARFARIN SODIUM 237 214 8 8
METOPROLOL SUCCINATE 234 215 9 12
GLIMEPIRIDE 217 158 10 50
HYDROCODONE-ACETAMINOPHEN 195 153 S3 11 25
NEXIUM 194 119 12 28
METFORMIN HCL ER 191 145 13 56
AMLODIPINE BESYLATE 190 165 14 4
HYDROCHLOROTHIAZIDE 180 123 15 11
GABAPENTIN 171 140 16 20
ZOLPIDEM TARTRATE 162 142 17 14
POLYETHYLENE GLYCOL 3350 151 77 18 91
SERTRALINE HCL 150 113 19 19
AZITHROMYCIN 149 114 20 39
TAMSULOSIN HCL 149 109 20 23
SPIRIVA 142 88 22 48
FLUTICASONE PROPIONATE 139 52 23 55
TRAZODONE HCL 137 99 24 21
ESCITALOPRAM OXALATE 135 128 25 27
TRAMADOL HCL 135 70 25 35
METFORMIN HCL 121 90 27 10
ALLOPURINOL 121 109 27 31
ATENOLOL 120 90 29 13
LYRICA 115 52 30 115
CRESTOR 113 85 31 18
CITALOPRAM HBR 112 91 32 24
PANTOPRAZOLE SODIUM 111 85 33 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 109 74 34 38
ROPINIROLE HCL 108 52 35 154
CLOPIDOGREL 102 79 36 46
LEVOFLOXACIN 102 64 36 96
JANUVIA 101 59 38 49
PROAIR HFA 100 43 39 64
CYMBALTA 97 68 40 41
PRAVASTATIN SODIUM 94 61 41 15
POTASSIUM CHLORIDE 90 76 42 30
PLAVIX 90 75 42 61
DONEPEZIL HCL 90 90 42 17
DIOVAN HCT 89 81 45 60
LANTUS SOLOSTAR 88 55 46 93
PREDNISONE 85 60 47 33
LIDODERM 83 72 48 66
ISOSORBIDE MONONITRATE ER 83 54 48 59
LIPITOR 81 44 50 47
FENTANYL 81 58 S2 50 74
ALENDRONATE SODIUM 80 46 52 29
QUETIAPINE FUMARATE 80 72 52 45
PEN NEEDLE 79 47 54 128
DEXILANT 77 63 55 142
QUINAPRIL HCL 77 65 55 86
MECLIZINE HCL 76 55 57 137
RISPERIDONE 76 50 57 40
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 49 59 118
ADVAIR DISKUS 71 55 60 37
METHYLPREDNISOLONE 71 56 60 148
IBUPROFEN 69 55 62 114
BETAMETHASONE DIPROPIONATE 67 33 63 283
AMOX TR-POTASSIUM CLAVULANATE 67 44 63 123
NAMENDA 66 66 65 34
AMITRIPTYLINE HCL 65 52 R 66 150
TRICOR 64 41 67 101
DIGOXIN 64 63 67 52
MELOXICAM 64 45 67 67
ENOXAPARIN SODIUM 63 47 70 214
DIOVAN 63 63 70 16
DIVALPROEX SODIUM 62 25 72 53
LOVASTATIN 62 36 72 44
RANITIDINE HCL 61 47 74 63
SYMBICORT 59 25 75 147
CARVEDILOL 57 47 76 36
FENOFIBRATE 57 43 76 109
KLOR-CON M20 57 45 76 70
LEVOCETIRIZINE DIHYDROCHLORIDE 55 31 79 207
VERAPAMIL ER 54 33 80 116
OXYCONTIN 53 30 S2 81 98
SYNTHROID 52 52 82 42
AZELASTINE HCL 52 30 82 308
ENALAPRIL MALEATE 51 47 84 83
MIRTAZAPINE 51 50 84 26
HUMALOG 50 15 86 116
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.